gr 89696 has been researched along with 3,4-dichloro-n-methyl-n-(2-(1-pyrrolidinyl)cyclohexyl)-benzeneacetamide, (trans)-(-)-isomer in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Autar, R; Bouzanne des Mazery, R; Fröhlich, R; Molenveld, P; Schepmann, D; Soeberdt, M; Sterk, GJ; Storcken, RP; van der Haas, RN; van Oss, B; Wünsch, B | 1 |
1 other study(ies) available for gr 89696 and 3,4-dichloro-n-methyl-n-(2-(1-pyrrolidinyl)cyclohexyl)-benzeneacetamide, (trans)-(-)-isomer
Article | Year |
---|---|
Conformationally restricted κ-opioid receptor agonists: Synthesis and pharmacological evaluation of diastereoisomeric and enantiomeric decahydroquinoxalines.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Crystallography, X-Ray; Inhibitory Concentration 50; Magnetic Resonance Spectroscopy; Molecular Structure; Piperazines; Protein Binding; Pyrrolidines; Quinoxalines; Receptors, Opioid, kappa; Stereoisomerism | 2015 |